Assessment of cecal microbiota modulation from piglet dietary supplementation with copper

BMC Microbiology

Table 1 Alpha diversity metrics means by treatment, ANOVA, and orthogonal contrasts analysis

Treatment	Alpha diversity metrics
	Berger Parker	Buzas Gibson	Chao 1	Dominance	Equitability	Jost	Jost 1	Richness	Robbins	Shannon	Simpson
Control	0.1190	0.0011	723.2250	0.9692	0.6827	49.1000	88.9250	722.0000	0.1607	1.9475	0.0306
Cu-MHAC	0.0998	0.0008	199.1000	0.9750	0.6957	59.6000	104.7500	798.0000	0.1400	2.0150	0.0250
CuSO₄	0.0968	0.0011	745.4000	0.9787	0.6940	59.4500	101.0750	744.2500	0.1477	1.9900	0.0212
TBCC	0.1212	0.0008	796.0500	0.9700	0.6832	51.8500	96.7000	795.0000	0.1367	1.9825	0.0301
CV_mean (%)	30.7300	38.1200	8.7000	0.5000	3.2600	21.6200	17.0200	8.7400	17.6000	3.6300	17.9800
P -value for ANOVA
Trial	0.5294	0.0167**	0.1433	0.9306	0.0689*	0.4072	0.2818	0.1436	0.0434**	0.2635	0.8741
Treatment	0.6451	0.4934	0.3300	0.0908*	0.7711	0.5155	0.5890	0.3313	0.5784	0.6298	0.0892*
P -value for Orthogonal contrasts
Control vs. Others	0.5141	0.3868	0.1666	0.0920*	0.5374	0.2762	0.2410	0.1671	0.2219	0.2703	0.0989*
Cu-MHAC vs. (CuSO₄ + TBCC)	0.5177	0.2288	0.2272	0.0916*	0.7495	0.6191	0.9732	0.2281	0.5642	0.8466	0.0867*
CuSO₄ vs. TBCC	0.3860	0.7304	0.9495	0.1772	0.4476	0.3765	0.5084	0.9505	0.8616	0.5370	0.1676

Significance level was considered p-value < 0.05**, and p-value from 0.05 to 0.10 indicated a statistical trend*. Coefficient of variation of the mean (CV_mean)

ISSN: 1471-2180